Nonte Limited secures £100k for research data integrity platform

Research laboratories and pharmaceutical companies requiring audit-ready logs for pre-clinical data can use a provenance platform developed by Nonte Limited. The Warwick-based company has secured £100k in new funding at an estimated post-money valuation of £5.6m.

Incorporated in April 2025, the business provides a solution that records every change to experimental data by integrating with electronic lab notebooks (ELNs), laboratory information management systems (LIMS), and spreadsheets. This system creates tamper-evident logs and full lineage to assist with regulatory and quality assurance requirements for translational research.

The platform is designed to provide defensible data for academic institutions. This funding round was processed through a share allotment in September 2026 (with formal documentation filed during the same month). No previous funding rounds or specific financial metrics such as revenue or employee headcount were disclosed.